Market closed

Agios/$AGIO

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Agios

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Ticker

$AGIO
Trading on

Industry

Biotechnology

Employees

385

Agios Metrics

BasicAdvanced
$3.4B
Market cap
5.00
P/E ratio
$11.80
EPS
0.75
Beta
-
Dividend rate
$3.4B
0.75
$59.29
$20.40
601K
8.993
8.438
2.737
3.74
-18.17%
53.65%
5.002
101.47
2.07
2.07
-10.104
36.79%
-397.66%
-22.09%

What the Analysts think about Agios

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Agios stock.

Agios Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Agios Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AGIO

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Agios stock?

Agios (AGIO) has a market cap of $3.4B as of November 14, 2024.

What is the P/E ratio for Agios stock?

The price to earnings (P/E) ratio for Agios (AGIO) stock is 5 as of November 14, 2024.

Does Agios stock pay dividends?

No, Agios (AGIO) stock does not pay dividends to its shareholders as of November 14, 2024.

When is the next Agios dividend payment date?

Agios (AGIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Agios?

Agios (AGIO) has a beta rating of 0.75. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.